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Report Pursuant to Section 156 of Chapter 68 of the Acts of 2011:                                
Rates of Reimbursement to Providers in the MassHealth MCO Program 
 
In Section 156 of Chapter 68 of the Acts of 2011, the Legislature directed the Office of the 
Inspector General for the Commonwealth of Massachusetts (“Office”) to study and review 
MassHealth, the Massachusetts Medicaid Program.  This report, which focuses on containing 
certain MassHealth costs, is part of the study and review that was mandated by the Legislature. 
Lessons learned from the private health care market in Massachusetts are quite relevant to 
determining effective ways to contain MassHealth costs.  In particular, the Patrick 
administration and Attorney General Martha Coakley have done important work ascertaining 
problems and solutions relating to cost containment in the private health care market.  Both 
the Patrick administration and the Attorney General have issued a series of reports showing 
that provider market power has a significant effect on health care costs, and they have argued 
persuasively that regulation is a vital component of any effective system of health care cost 
containment in Massachusetts.  And since 2010, Governor Patrick, through the Massachusetts 
Division of Insurance, has pursued the unprecedented step of regulating health insurance 
premiums in the small group market.  In addition, for the past several years, the Office has 
consistently recommended that the Commonwealth implement measures to address undue 
provider market power and has recommended that the Division of Insurance use its existing 
authority to contain health care costs by regulating health insurance premiums.   
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In this context, the Office examines ways to save money for the Commonwealth by eliminating 
excessive MassHealth costs.  
Introduction 
MassHealth has two managed care programs operating side by side:  the MassHealth Managed 
Care Organization (“MMCO”) program and the Primary Care Clinician (“PCC”) plan.  As of 
June 2011, there were 1,307,106 MassHealth members, approximately 64% of which were in 
the two managed care programs – 489,873 in the MMCO program and 350,061 in the PCC plan.  
(MassHealth: The Basics – Facts, Trends and National Contest, Center for Health Law and 
Economics, University of Massachusetts Medical School, October 2011, p. 16.)  At any time, 
MassHealth members in these managed care programs may switch between the two programs 
and, within the MMCO program, may switch among the various MMCOs.   
The PCC plan is a fee-for-service managed care program with a “gatekeeper” physician, who is a 
primary care clinician chosen by the MassHealth member.1
                                                          
1 The “gatekeeper” primary care clinician provides the member with checkups and other primary care services, and 
also manages the member’s health care services.  If the member wants to see a specialist or needs other services, 
the member must obtain a referral from the primary care clinician.  The member can obtain physician services only 
from those doctors that accept MassHealth. 
  MassHealth reimburses providers 
directly under the PCC plan and does so at regulated rate levels.  The three main regulated 
payment types are Standard Payment Amount Per Discharge (“SPAD”) for inpatient services at 
acute care hospitals, Payment Amount Per Episode (“PAPE”) for outpatient services at acute 
care hospitals, and a general Medicaid fee schedule for professional services.  The regulated 
rates are considered by many providers to be low, at least relative to other provider 
reimbursements from public and private payers. 
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In contrast to the PCC plan, the MMCO program can fairly be characterized as a “capitated” 
managed care program.  There are five MMCOs:  Boston Medical Center HealthNet Plan, Fallon 
Community Health Plan, Inc., Health New England, Inc., Neighborhood Health Plan, Inc., and 
Network Health, Inc. (“Network Health”).  The Commonwealth pays the MMCOs fixed 
capitation rates per member, and the MMCOs are responsible for all the health care expenses 
of their members.  The MMCOs, in turn, contract with health care providers to provide health 
care services to MassHealth members.  For the most part, the MMCOs do not pay hospitals and 
health care professionals at regulated reimbursement rates, but instead negotiate those 
reimbursement rates with the hospitals and with the health care professionals. 
In general, in order to entice providers to participate in the MMCO program, the MMCOs pay 
higher reimbursement rates than they do under the PCC plan.  And in those cases in which the 
provider has substantial market power, either because of a geographic monopoly or because of 
the reputation of the provider, the provider sometimes negotiates reimbursement rates far in 
excess of the PCC rates.  In fact, there are instances in which providers have negotiated rates 
that are several times higher than the PCC rates. 
The Office of the Inspector General first examined the issue of excessive MassHealth 
reimbursement rates in March 2010 after Network Health’s President, Christina Severin, 
submitted testimony as part of the 2010 Health Care Cost Trend Hearings held by the Division 
of Health Care Finance and Policy (“DHCFP”).  In particular, Ms. Severin testified as follows:  
It is, and always has been, an expectation in the Medicaid MCO market that 
contracted providers will be paid at a level above Medicaid and the relative 
“percentage of Medicaid” is the most common factor that is considered by 
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payors and hospitals in determining contract rates.  Hospitals insist that 100% 
Medicaid payment does not cover the costs of providing services to Medicaid 
enrollees and that therefore a percentage above Medicaid is expected.  For 
Commonwealth Care members, the assumption is even greater since the 
Medicaid SPAD was developed incorporating a large pediatric experiential base.  
Nevertheless, it is assumed in the market that the base Medicaid payment level 
set by MassHealth provides a starting point for the relative cost variance of the 
contracted hospitals since this base Medicaid payment is calculated by 
MassHealth based upon case mix and cost factors of the respective hospitals. . . . 
In many geographic areas, hospitals enjoy geographic market dominance and use 
this advantage to selectively contract with the highest bidder or bidders.  
Network Health has been forced to pay higher rates in order to retain key service 
areas.  Despite exhaustive efforts to reduce contracted rates, Network Health 
has, in certain markets, been forced to accept rates significantly above Medicaid 
in order to serve its members and provide sufficient choice and access. 
(Testimony of Christina Severin, President of Network Health, 2010 Health Care Cost Trends 
Hearings, March 5, 2010, pp. 3-4.) 
In discussions with the MMCOs, the Office learned that the problem of excessive 
reimbursements for providers in the MMCO program is widespread and not unique to Network 
Health.  Moreover, the problem affects all three main areas of services – inpatient, outpatient, 
and professional.   
In order to evaluate the magnitude of the problem, the Office collected reimbursement data 
from all five MMCOs and compared those data with analogous reimbursements calculated 
using the PCC methodology for determining reimbursement rates.2
                                                          
2 These analogous reimbursements are referred to here as “Equivalent MassHealth PCC Reimbursements.” 
  To produce an 
apples-to-apples comparison, adjustments were made to the inpatient data to account for 
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differences in case mix between the PCC plan and the MMCO program.3  Ideally, similar 
adjustments would be made to the outpatient data, but the MMCOs do not currently collect 
and evaluate the data necessary to determine the outpatient case-mix differences between the 
PCC plan and the MMCO program.4
Results and Analysis 
  For professional services, case mix is not a significant issue 
because most of these services are paid based on fee schedules, thereby implicitly adjusting for 
case mix.    
1. Differences in Reimbursements between the MMCO Program and the PCC Plan  
For claims in the most recently completed MMCO fiscal year (Fiscal Year 2011 -- from 
October 1, 2010 to September 30, 2011), the MMCO reimbursements were, on average, 
substantially higher than the Equivalent MassHealth PCC Reimbursements:  28% higher for 
inpatient services, 38% higher for outpatient services,5
 
 and 33% higher for professional 
services, with a weighted average of 33% higher overall.  The corresponding dollar differences 
were approximately $113 million, $142 million, and $73 million, respectively, for a total of 
$328 million.  (See Table 1 below)    
                                                          
3 The inpatient case mix for MMCO members is more favorable than the inpatient case mix for PCC members, 
which reflects the tendency of MMCO members to be healthier on average than PCC members.   
 
4 Note that hospital-specific PCC PAPE rates were, however, used to determine the Equivalent MassHealth PCC 
Outpatient Reimbursements, so outpatient case-mix differences among the acute hospitals are implicitly taken 
into consideration.  This is especially relevant when examining the variation in reimbursements to providers. 
 
5 If for outpatient services, as is true for inpatient services, the healthier MMCO member population causes the 
MMCO case mix to be more favorable than the PCC case mix, then the reported difference in outpatient 
reimbursements between the MMCO program and the PCC plan would be even larger.  
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TABLE 1 
Comparison of FY2011 Reimbursements from MMCOs with  
Equivalent MassHealth PCC Reimbursements 
Service Type 
Amounts Paid  
to Providers 
Equivalent 
MassHealth 
PCC Reimbursements 
Percentage of 
Equivalent MassHealth 
PCC Reimbursements 
$ Difference 
INPATIENT SERVICES $508,605,363 $395,851,873 128% $112,753,490 
OUTPATIENT SERVICES $520,834,550 $378,652,608 138% $142,181,941 
PROFESSIONAL SERVICES $293,373,205 $220,699,466 133% $72,673,739 
TOTAL $1,322,813,117 $995,203,948 133% $327,609,170 
 
The differential between what providers would be reimbursed using the PCC methodology and 
what they are reimbursed under the MMCO program raises serious questions about the 
viability of the MMCO program as currently structured.  While it is theoretically possible that 
the MMCO program produces enough savings in utilization to outweigh the large differentials in 
reimbursement rates, there is little evidence to support that possibility.  In fact, studies of the 
private market have indicated that managed care savings come primarily from price reductions 
and not from decreases in utilization.  (See, e.g., Cutler, D., McClellan, and Newhouse, J., “How 
does managed care do it?”  RAND Journal of Economics, Vol. 31, No. 3, Autumn 2000, 
pp. 526-548.)    
A recent national study of managed care in Medicaid suggested that in states where the 
regulated reimbursement rates for providers are low, managed care did not produce overall 
savings.  (See Duggan, M., and Hayford, T., “Has the Shift to Managed Care Reduced Medicaid 
Expenditures?  Evidence from State and Local-Level Mandates,” Working Paper 17236, National 
Bureau of Economic Research, July 2011.)6
                                                          
6 Compare, The Lewin Group, “Medicaid Managed Care Cost Savings – A Synthesis of 24 Studies,” Prepared for 
America’s Health Insurance Plans, 2009.  
  In Massachusetts, there have been conflicting 
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claims, by the MMCOs on the one hand and the Patrick administration on the other, about 
whether the MMCO program is more cost effective than the PCC plan.   
Based on the results of the Office’s investigation of reimbursement rates under the MMCO 
program and the PCC plan, it appears that currently the overall structure of the PCC plan is 
more cost effective than that of the MMCO program.  The point of comparing the cost 
structures of the PCC plan and the MMCO program, however, is not to try to determine which 
one is more cost effective (and, presumably, then to argue for shifting members from one to 
the other).  Instead, the comparison demonstrates that the Commonwealth should modify the 
MMCO program to merge the best aspects of both the MMCO program and the PCC plan.  
Specifically, the coordination-of-care and utilization-review benefits of the MMCO program 
should be preserved, but the mechanism for reimbursing providers should be modified to use 
the PCC methodology to establish limits on reimbursement rates in the MMCO program. 
In recent years, the Patrick administration recognized the need to lower the provider 
reimbursement rates under the MMCO program and instituted new limits on the capitation 
rates for MMCOs.  And for Fiscal Year 2012, the capitation rates were, for the first time, 
calculated based on the assumption that provider reimbursement rates would be 105% of the 
case-mix-adjusted SPAD rates for inpatient services, 105% of the PAPE rates for outpatient 
services, and 110% of the PCC medical fee schedule rates for professional services.  MMCOs 
could pay providers in excess of those limits, but MMCOs received capitation rates that 
excluded any such excess payments.   
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The Office examined projected Fiscal Year 2012 data to determine the impact of this new rating 
policy.7  The policy did produce some savings in MMCO reimbursements to providers.  For 
projected Fiscal Year 2012, MMCO reimbursements were somewhat lower than for Fiscal 
Year 2011, but were still, on average, substantially higher than the Equivalent MassHealth PCC 
Reimbursements:  18% higher for inpatient services, 32% higher for outpatient services,8
TABLE 2 
 and 
30% higher for professional services, with a weighted average of 26% higher overall.  The 
corresponding dollar differences were approximately $71 million, $123 million, and $66 million, 
respectively, for a total of $260 million.  (See Table 2) 
Comparison of Projected FY2012 Reimbursements from MMCOs 
with Equivalent MassHealth PCC Reimbursements 
Service Type 
Amounts Paid  
to Providers 
Equivalent 
MassHealth 
PCC Reimbursements 
Percentage of 
Equivalent MassHealth 
PCC Reimbursements 
$ Difference 
INPATIENT SERVICES $464,799,919 $394,051,560 118% $70,748,359 
OUTPATIENT SERVICES $506,552,019 $383,177,329 132% $123,374,690 
PROFESSIONAL SERVICES $287,620,440 $221,688,663 130% $65,931,777 
TOTAL $1,258,972,379 $998,917,553 126% $260,054,825 
 
The Office acknowledges that the Patrick administration has taken important steps to limit 
excessive reimbursements to providers under the MMCO program.  Setting the target provider 
reimbursement rates implicit in the MMCO capitation rates was a good first step.  As a direct 
result of the administration’s revision of the provider reimbursement rates implicit in the 
MMCO capitation rates, reductions of about $67 million in reimbursement rates are projected 
to be realized in Fiscal Year 2012.  That represents 21% of the $328 million difference between 
                                                          
7 The MMCOs were asked to project FY2012 data by using the FY2011 data, revised to reflect any differences in 
provider contracts between the two fiscal years.    
 
8 Again, if for outpatient services, as is true for inpatient services, the healthier MMCO member population causes 
the MMCO case mix to be more favorable than the PCC case mix, then the reported difference in outpatient 
reimbursements between the MMCO program and the PCC plan would be even larger.  
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the MMCO reimbursements and the Equivalent MassHealth PCC Reimbursements for Fiscal 
Year 2011. 
What the Office’s study shows, however, is that lowering the capitation rates, by itself, does 
not have enough of an effect on the relative bargaining power of the MMCOs and the providers 
to address the issue of excessive reimbursements adequately.  The MMCOs already have a 
strong financial incentive to negotiate the lowest possible provider reimbursement rates.  
Lowering the capitation rates paid to the MMCOs has not provided the MMCOs with sufficient 
leverage in negotiating with the providers.  A more direct way of reducing provider 
reimbursement rates is therefore needed to augment the administration’s efforts in this area. 
2. Variation in Provider Reimbursement Rates 
The Office examined the variation in provider reimbursement rates paid by the MMCOs.  
Reimbursement rates for all services provided in Fiscal Year 2011 varied widely.  There were 
instances in which individual MMCOs paid reimbursement rates that varied by more than five 
to one.  Even when the data for all the MMCOs were combined, variation in reimbursement 
rates was substantial, with some providers receiving average MMCO reimbursement rates that 
were five times higher than other providers received.   
Below are tables that show the variation in outpatient and professional reimbursement rates 
using the Fiscal Year 2011 data for all MMCOs combined.9
 
     
                                                          
9 Similar data for inpatient services adjusted for case mix are not available because most of the MMCOs did not 
have easy access to case-mix-adjusted inpatient data by provider.      
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A. Data for Outpatient Services 
Table 3 shows the variation in outpatient data for the top 15 acute hospital recipients of Fiscal 
Year 2011 outpatient reimbursements from all of the MMCOs.  The variation ranged from 103% 
to 248% of what would have been paid under the MassHealth PCC plan.  
TABLE 3 
Top 15 Recipients of FY2011 Outpatient Reimbursements from MMCOs 
(Amounts Received Ranged between $10 Million and $55 Million)  
Acute Hospital 
Percentage of 
Equivalent MassHealth 
PCC Reimbursements 
Rank by Total Outpatient 
Reimbursements 
Received by Hospital 
from all MMCOs 
HEALTHALLIANCE-BURBANK HOSPITAL 248% 13 
BRIGHAM & WOMEN'S HOSPITAL  235% 9 
TUFTS MEDICAL CENTER 210% 8 
BERKSHIRE MEDICAL CENTER 178% 10 
STEWARD ST. ANNE'S HOSPITAL 169% 12 
NORTH SHORE MEDICAL CENTER 159% 14 
MASSACHUSETTS GENERAL HOSPITAL 152% 6 
SOUTHCOAST HOSPITAL GROUP 148% 7 
BOSTON MEDICAL CENTER 144% 2 
TOP 15 COMBINED 143%  
ALL HOSPITALS COMBINED 138%   
UMASS MEMORIAL MEDICAL CENTER 136% 3 
LAWRENCE GENERAL HOSPITAL 135% 15 
CHILDREN'S HOSPITAL MA 130% 4 
BAYSTATE MEDICAL CENTER 125% 1 
BETH ISRAEL DEACONESS MEDICAL CTR 122% 11 
CAMBRIDGE HOSPITAL 103% 5 
 
Table 4 below shows the variation in outpatient data for the remaining acute hospital recipients 
of Fiscal Year 2011 outpatient reimbursements from all of the MMCOs.  The variation ranged 
from 78% to 412% of what would have been paid under the MassHealth PCC plan. 
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TABLE 4 
Other Recipients of FY2011 Outpatient Reimbursements from MMCOs 
(Ranked #16 to #65: Amounts Received Ranged Up to $10 Million) 
 
 
Acute Hospital 
Percentage of 
Equivalent MassHealth 
PCC Reimbursements 
Rank by Total Outpatient 
Reimbursements 
Received by Hospital 
from all MMCOs 
CLINTON HOSPITAL 412% 50 
MARLBOROUGH HOSPITAL 411% 41 
NEWTON-WELLESLEY HOSPITAL 252% 44 
NEW ENGLAND BAPTIST HOSPITAL 218% 63 
MILTON HOSPITAL 211% 58 
NANTUCKET COTTAGE HOSPITAL 205% 64 
FAULKNER HOSPITAL 203% 43 
MARTHA'S VINEYARD HOSPITAL 176% 62 
SOUTH SHORE HOSPITAL 174% 22 
NORTH ADAMS REGIONAL HOSPITAL 169% 39 
METROWEST 166% 30 
MOUNT AUBURN HOSPITAL 165% 47 
ATHOL MEMORIAL HOSPITAL 164% 59 
WING MEMORIAL HOSPITAL 162% 33 
STEWARD CARNEY HOSPITAL 158% 37 
COOLEY DICKINSON HOSPITAL 156% 38 
STEWARD NORWOOD HOSPITAL 154% 52 
BAYSTATE MARY LANE HOSPITAL 152% 57 
STEWARD NASHOBA VALLEY MEDICAL  CENTER 151% 60 
BAYSTATE FRANKLIN MEDICAL CENTER 148% 34 
FAIRVIEW HOSPITAL 147% 54 
HALLMARK HEALTH SYSTEM 142% 23 
ST. VINCENT HOSPITAL 141% 24 
ALL HOSPITALS COMBINED 138% 
 JORDAN HOSPITAL 135% 48 
LOWELL GENERAL HOSPITAL 132% 19 
BEVERLY HOSPITAL 130% 26 
HARRINGTON MEMORIAL HOSPITAL 129% 20 
HOSPITALS RANKED #16 to #65 COMBINED 129% 
 QUINCY MEDICAL CENTER 127% 53 
STEWARD HOLY FAMILY HOSPITAL 127% 25 
BROCKTON HOSPITAL 126% 18 
MILFORD REGIONAL MEDICAL CENTER 126% 42 
HENRY HEYWOOD MEMORIAL HOSPITAL 125% 35 
STEWARD MERRIMACK VALLEY HOSPITAL 123% 55 
MORTON HOSPITAL 120% 36 
SAINTS MEMORIAL MEDICAL CENTER 119% 27 
STEWARD GOOD SAMARITAN MEDICAL CENTER 117% 31 
WINCHESTER HOSPITAL 114% 46 
STEWARD ST. ELIZABETH'S MEDICAL CENTER 109% 45 
THE TRUSTEES OF NOBLE HOSPITAL 108% 51 
HOLYOKE MEDICAL CENTER, INC. 108% 17 
BETH ISRAEL DEACONESS -- NEEDHAM 107% 65 
ANNA JAQUES HOSPITAL 107% 56 
MASS. EYE & EAR INFIRMARY 106% 32 
STURDY MEMORIAL HOSPITAL 106% 40 
MERCY MEDICAL CENTER (MA) 104% 21 
CAPE COD HOSPITAL 103% 29 
EMERSON HOSPITAL 103% 61 
DANA-FARBER CANCER INSTITUTE 103% 16 
FALMOUTH HOSPITAL 100% 49 
LAHEY CLINIC HOSPITAL 78% 28 
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B. Data for Professional Services 
Table 5 shows the variation in professional services data for the top 10 physician group 
recipients of Fiscal Year 2011 professional reimbursements from all of the MMCOs.  The 
variation ranged from 107% to 262% of what would have been paid under the MassHealth 
PCC plan.  
TABLE 5 
Top 10 Recipients10
(Amounts Received Ranged Up to $50 Million)  
 of FY2011 Professional Reimbursements from MMCOs 
Physician Groups 
Percentage of 
Equivalent MassHealth 
PCC Reimbursements 
Rank by Total Professional 
Reimbursements Received 
from all MMCOs 
CHILDREN’S AFFILIATED 262% 1 
PARTNERS AFFILIATED 152% 3 
TOP 10 COMBINED 144%  
UMASS AFFILIATED 138% 4 
ALL PHYSICIAN GROUPS COMBINED 133%  
BAYCARE HEALTH PARTNERS 120% 2 
BOSTON MEDICAL CENTER AFFILIATED 117% 5 
BETH ISRAEL DEACONESS  114% 6 
COOLEY DICKINSON 111% 9 
LOWELL COMMUNITY HEALTH CENTER 111% 10 
CAMBRIDGE HEALTH ALLIANCE 109% 8 
GREATER LAWRENCE FAMILY HEALTH CENTER 107% 7 
 
 
Of particular interest is the comparison of those physician groups receiving more than 
$10 million each in professional reimbursements with those receiving less than $10 million each 
in professional reimbursements.  (See Table 6 below) 
 
                                                          
10 The list of the top 10 recipients of professional reimbursements includes only those physician groups receiving 
significant reimbursements from multiple MCOs.  
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 TABLE 6 
Comparison of Groups Receiving More Than $10 Million in Reimbursements  
with Groups Receiving Less Than $10 Million in Reimbursement 
Physician Groups 
Total Professional 
Reimbursements 
Received from all 
MMCOs 
Equivalent 
MassHealth PCC 
Reimbursements 
Percentage of 
Equivalent 
MassHealth PCC 
Reimbursements 
GROUPS RECEIVING MORE THAN $10 MILLION11 $167,184,855  $106,201,150 157% 
GROUPS RECEIVING LESS THAN $10 MILLION $126,188,350 $114,498,051 110% 
 
The groups receiving less than $10 million each in reimbursements were paid on average 110% 
of the Equivalent MassHealth PCC Reimbursements.  That amount matches the allowance for 
professional services in the MMCO capitation rates.  The six groups receiving more than 
$10 million each received much higher reimbursement rates – 157% of the Equivalent 
MassHealth PCC Reimbursements on average.  A substantial differential in reimbursements still 
remains even if the groups affiliated with Children’s Hospital are excluded from the analysis; 
specifically, the other five groups that each received more than $10 million were paid 135% of 
the Equivalent MassHealth PCC Reimbursements on average.  
Recommendation 
The above information is consistent with the findings of Attorney General Martha Coakley, who 
has shown that variation in prices in the private health care market in Massachusetts cannot be 
explained by differences in quality of care.  (See, generally, 2010 Report for Annual Public 
Hearing on Examination of Health Care Cost Trends and Cost Drivers Pursuant to G.L. c. 118G, 
§ 6 1/2(b), hereafter “2010 AG Report,” Office of Attorney General Martha Coakley, March 16, 
2010; 2011 Examination of Health Care Cost Trends and Cost Drivers Pursuant to G.L. c. 118G, 
                                                          
11 These groups are the top five groups listed in Table 5 and one other group not listed in that table because the 
group received significant reimbursements from only one MMCO. 
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§ 6 1/2(b), Office of Attorney General Martha Coakley, August 3, 2011.)  Attorney General 
Coakley also demonstrated that these variations are correlated with market leverage, such as 
provider size, geographic location, brand name, and niche or specialty service line offered.  (See 
2010 AG Report, supra, at 28-33.)  Similar findings about price variation and market leverage 
were reported by DHCFP.  (See Massachusetts Health Care Cost Trends:  Price Variation in 
Health Care Services, DHCFP, May 2011, revised June 3, 2011.)  
The data underlying the Office’s study indicate that the same types of market leverage 
problems as those identified by the Attorney General and DHCFP with respect to the private 
market also affect the MMCO program, where many providers with market clout have 
negotiated reimbursement rates well in excess of those produced by the PCC plan 
reimbursement methodology.  In this type of dysfunctional market, a PCC-like mechanism for 
counteracting the effects of market leverage would produce substantial savings for the MMCO 
program. 
There are likely several ways to bring the MMCO provider reimbursement rates more in line 
with those that would be produced using the PCC method of determining reimbursement rates.  
Any reasonable proposal that would achieve that goal deserves serious consideration.  The 
Office offers the following such proposal, which would modify the MMCO program: 
1. Out-of-network providers that have a contract with MassHealth should be 
required to accept, from any MMCO, case-mix-adjusted MassHealth SPAD rates 
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for inpatient services,12
2. Reimbursements to in-network providers should be limited to no more than 
105% of the applicable MassHealth case-mix-adjusted SPAD rates for inpatient 
services,
 MassHealth PAPE rates for outpatient services, and the 
MassHealth fee schedule for professional services.  Currently, the MassHealth 
contract with providers requires them – when out of an MMCO’s network – to 
accept MassHealth reimbursement rate levels from the MMCO for all emergency 
and post-stabilization services.  Establishing limits on all services would lower 
payments to out-of-network providers, but more important, would provide 
leverage to the MMCOs in negotiating reasonable in-network reimbursement 
rates.   
13
                                                          
12 MassHealth would calculate these rates by applying the methodology for determining the SPAD rates currently 
to the MMCO-specific inpatient data for each hospital.  
 105% of the applicable MassHealth PAPE rates for outpatient services, 
and 110% of the applicable MassHealth fee schedule rates for professional 
services.  The 105%, 105%, and 110% caps, respectively, (as opposed to a 
uniform cap of 100%) would be permitted as compensation to providers for 
participating in the network of an MMCO.  Larger payments, which are prevalent 
today, are primarily the result of undue provider market power.  These excessive 
payments have driven up costs for the Commonwealth and should be eliminated 
from MassHealth.  
 
13 Again, MassHealth would calculate these rates by applying the methodology for determining the SPAD rates 
currently to the MMCO-specific inpatient data for each hospital. 
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The Office estimates savings of more than $200 million annually resulting from this proposal.  
Any reductions in provider reimbursements by MMCOs would be passed along to the 
Commonwealth in the form of lower capitation rates included in the MassHealth contracts with 
the MMCOs.14
The Office is aware that some providers will claim that this proposal should not be adopted 
because they believe it will result in reimbursement rates at levels lower than the current cost 
of providing those services.  In response, the Office makes the following observations: 
  The Office recommends that the above approach be implemented 
administratively through the MassHealth RFA process.  No new legislation would be needed. 
1. Claiming that reimbursement rates do not cover provider costs begs the 
question as to what costs are reasonable for the providers to incur.  A thorough 
examination of the underlying provider costs would be very illuminating and is, 
in the Office’s view, necessary in order for the Commonwealth ever to control 
the amounts paid for health care in both the public and private markets.   
2. How is the cost of providing services defined by providers?  For example, in 
instances where provider costs include compensation paid to health care 
professionals and staff, are all increases in such compensation defined by 
providers as “costs” that should be reimbursed?       
                                                          
14 Since the Office’s recommendations limit provider reimbursements to levels similar to those underlying the 
current MMCO capitation rates, one might be tempted to conclude that adopting the recommendations would 
produce no savings.  But dramatically reducing the payments by MMCOs would clearly enable the MMCOs to 
accept much lower capitation rates, and the Office’s discussions with MMCO staff members confirmed this point.  
As for the related issue of how any MMCOs have made profits while paying providers much more than the 
amounts allowed in the capitation rates, one possible explanation is that other components underlying the 
calculation of the capitation rates are overly generous.  
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3. Accepting actual provider costs as the basis for determining reimbursement 
rates is tantamount to establishing a cost-plus reimbursement system, which 
eliminates the incentive for providers to control their own costs.  The Patrick 
administration and previous administrations have rightly rejected the notion that 
MassHealth should reimburse all provider costs.   
4. While the state and federal public payers been able to prevent providers from 
being reimbursed on a cost-plus basis, payers in the private health care market 
have generally been unable to prevent providers from being reimbursed on that 
basis.  Due to the cost-plus nature of the private health care market, price 
increases in that market over the past decade have vastly exceeded price 
increases to buyers in virtually every non-health-care private market in 
Massachusetts and in the nation.     
5. The MMCO program was put in place, in part, as a cost-effective alternative to 
the PCC plan.  The MMCO program was certainly not supposed to be a 
mechanism for providers to circumvent state regulation and receive 
reimbursement rates substantially higher than those established for the 
MassHealth PCC plan. 
6. The Office’s proposal allows MMCOs to pay reimbursement rates that are higher 
than those in the PCC plan and that are consistent with the reimbursement rate 
assumptions underlying the current MMCO capitation rates.   
18 
 
 
The Office is mindful that the Legislature is currently working on a health care cost control bill, 
which contains many provisions that could affect the efficacy of the Office’s proposal.  The 
Office is also aware that the Patrick administration is considering transitioning to global 
payment structures in the MassHealth program.  The Office recommends that, as the 
Legislature and the Patrick administration examine reform proposals affecting MassHealth 
reimbursements, due consideration be given to the concerns raised in this study.  In particular, 
it is recommended that a specific PCC-like reimbursement mechanism should be implemented 
to counter the effects of provider market leverage.  Otherwise, the results of the Office’s study, 
as well as the work of the Attorney General and of DHCFP, indicate that the Commonwealth will 
likely pay excessive provider reimbursement rates, regardless of whether MassHealth moves to 
a global payment structure.   
Conclusion 
Due to provider market power issues similar to those identified by Attorney General Coakley 
and DHCFP for the private health care market, providers in the MassHealth MMCO program are 
reimbursed at much higher rates than they are in the MassHealth PCC plan.  (Also, variation in 
MMCO reimbursement rates is substantial, with some providers receiving average rates five 
times higher than other providers receive.)  In Fiscal Year 2011, rates were about 33% higher in 
the MMCO program than in the PCC plan on average, costing the Commonwealth an estimated 
$328 million in excessive reimbursements.  The Patrick administration implemented new rating 
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rules for Fiscal Year 2012, and, as a result, excessive provider reimbursements were reduced by 
an estimated $67 million (or 21%), lowering the $328 million amount to $260 million.   
In order for the Commonwealth to achieve additional savings for the MMCO program, the 
Office of the Inspector General recommends that the administration use its existing regulatory 
authority to establish a PCC-like mechanism to control excessive reimbursements.  The Office 
proposes that, in the adoption of a PCC-like mechanism, the administration use the very same 
benchmarks underlying the Fiscal Year 2012 MMCO capitation rates.  This would help the 
MMCOs negotiate lower reimbursement rates for those providers that possess undue market 
power, resulting in more than $200 million in annual savings for the Commonwealth.   
